Oligo Factory
John VanAlsten has an extensive work experience in the pharmaceutical industry. John is currently the Director at Oligo Factory since September 2022. Previously, they worked at Nitto Denko Avecia Inc. as a Group Leader from October 2018 to October 2022. Prior to that, they were a Sci Fellow II (chemical engineering) at Vertex Pharmaceuticals from October 2011 to March 2018. John started their career at Pfizer in 1999, where they held the positions of Sr. Research Engineer and Lead Engineer. John'sresponsibilities included overseeing drug substance process development, process qualification, and manufacturing campaigns, as well as developing and managing multistep processes for deliveries of investigational and commercial APIs. John also authored drug substance sections of NDAs. In addition, they led continuous processing technology teams, developed processes for candidate APIs, and implemented continuous improvement programs for Medrol® supply chain.
John VanAlsten has a Ph.D. in Chemical Engineering from the University of Illinois Urbana-Champaign. Prior to that, they earned a Bachelor of Science degree in Chemistry from Hope College.
This person is not in any teams
Oligo Factory
Oligo Factory is a leader in DNA/RNA oligonucleotide synthesis at scale. We were founded in 2006 by individuals with expertise in oligo synthesis technology as well as the oligo service business. The company’s goal was and is to provide oligonucleotides, high-quality purified DNA and RNA, at medium- to large-scale quantities to the research and life science communities. The Oligo Factory team is made up of skilled chromatographers, synthesis chemists, instrumentation engineers and commercialization specialists with more than 60 yrs of combined experience. We pride ourselves on service, cost-effective product delivery and attention to detail bc that’s what our customers need and deserve. We continue to invest in people and technology to serve the growing demands of scientific discoveries. We are dedicated to providing the highest quality oligonucleotides that drive a better future for humankind.